XML 104 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation and Other Incentive Plans - Options, Performance Options, RSUs, and Market Stock Units (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2022
$ / shares
shares
No. of Options Outstanding  
Balance at end of period (in shares) 2,771
Awards exercisable (in shares) 2,065
Stock Options  
No. of Options Outstanding  
Balance at end of period (in shares) 1,587
Granted (in shares) 153
Releases/Exercised (in shares) (734)
Forfeited/Canceled (in shares) (10)
Balance at end of period (in shares) 996
Awards exercisable (in shares) 684
Wtd. Avg. Exercise Price of Shares  
Balance at end of period (USD per share) | $ / shares $ 92
Granted (USD per share) | $ / shares 227
Releases/Exercised (USD per share) | $ / shares 70
Forfeited/Canceled (USD per share) | $ / shares 183
Balance at end of period (USD per share) | $ / shares 128
Awards exercisable (USD per share) | $ / shares $ 95
Restricted Stock Units  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 924
Granted (in shares) 776
Releases/Exercised (in shares) (408)
Forfeited/Canceled (in shares) (81)
Balance at end of period (in shares) 1,211
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 199
Granted (USD per share) | $ / shares 217
Releases/Exercised (USD per share) | $ / shares 157
Forfeited/Canceled (USD per share) | $ / shares 193
Outstanding at end of period (USD per share) | $ / shares 211
Awards exercisable (USD per share) | $ / shares $ 0
Restricted Stock  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 209
Granted (in shares) 48
Releases/Exercised (in shares) (143)
Forfeited/Canceled (in shares) 0
Balance at end of period (in shares) 114
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 203
Granted (USD per share) | $ / shares 217
Releases/Exercised (USD per share) | $ / shares 195
Forfeited/Canceled (USD per share) | $ / shares 0
Outstanding at end of period (USD per share) | $ / shares 224
Awards exercisable (USD per share) | $ / shares $ 0
Performance Options  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 2,368
Granted (in shares) 122
Releases/Exercised (in shares) (830)
Adjustment for payout factor (in shares) 115
Balance at end of period (in shares) 1,775
Awards exercisable (in shares) 1,381
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 91
Granted (USD per share) | $ / shares 222
Releases/Exercised (USD per share) | $ / shares 72
Adjustment for payout factor (USD per share) | $ / shares 133
Outstanding at end of period (USD per share) | $ / shares 112
Awards exercisable (USD per share) | $ / shares $ 91
Market Stock Units  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 120
Granted (in shares) 43
Releases/Exercised (in shares) (80)
Adjustment for payout factor (in shares) 20
Balance at end of period (in shares) 103
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 147
Granted (USD per share) | $ / shares 244
Releases/Exercised (USD per share) | $ / shares 140
Adjustment for payout factor (USD per share) | $ / shares 129
Outstanding at end of period (USD per share) | $ / shares 192
Awards exercisable (USD per share) | $ / shares $ 0
Performance Stock Units  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 128
Granted (in shares) 68
Releases/Exercised (in shares) (48)
Adjustment for payout factor (in shares) 21
Balance at end of period (in shares) 169
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 210
Granted (USD per share) | $ / shares 248
Releases/Exercised (USD per share) | $ / shares 217
Adjustment for payout factor (USD per share) | $ / shares 217
Outstanding at end of period (USD per share) | $ / shares 226
Awards exercisable (USD per share) | $ / shares $ 0